Patient Selection Faulted
However, the findings of the original PACE trial have been criticized by patients and experts in the field, who cite
methodological issues and point to the
lack of precision in patient selection among its flaws.
In recruiting patients, the researchers relied on the 1991 "
Oxford Criteria" for CFS, which define "a syndrome characterized by fatigue as the principal symptom," and specify that "the fatigue is severe, disabling, and affects physical and mental functioning." In addition, the fatigue must have been present for more than 6 months and for more than 50% of the time and not be explained by other diagnoses.
In contrast, more recent criteria for the condition known as myalgic encephalomyelitis (ME), such as those given in the
2003 Canadian Clinical Case Definition, require the hallmark symptom of postexertional malaise, along with sleep dysfunction, pain, neurocognitive manifestations, and at least one symptom from a list of autonomic, neuroendocrine, and/or immune manifestations to make the diagnosis. (A 2011 revision to the Canadian criteria drops the 6-month requirement for fatigue and makes other changes in attempts to identify an even more homogenous group of patients, but the revision has not yet been validated.)
The ME criteria are viewed as capturing a sicker population, but at this time, patients meeting any of the various criteria are typically lumped together under the heading of ME/CFS.
Andreas M. Kogelnik, MD, PhD, founder and director of the Open Medicine Institute, told
Medscape Medical News, "While physical deconditioning is a factor in ME/CFS patients, time and again
we've seen clear evidence in practical community settings that CBT and GET can be extremely detrimental to a patient's well-being and treatment course. The PACE trial did little to address the heterogeneity of the ME/CFS population, nor did it account well for severity of illness and fragility of many of these patients. CBT and GET need to be used very cautiously."